Experimental drug shows promise in reversing memory loss for early Alzheimer’s patients

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer’s disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup